STAT3 and neoplasm: Of note, preclinical studies proposed that the combination of JAK inhibitor and Taxol extracted from TW might be conducive to weakening tumor load for inflammatory breast cancer and have given the evidence on showing good tolerance to its clinical activity (Lynce et al., 2021), suggesting tightness between TW and the JAK/STAT3 axis.